1Acharya SK. Dasarathy S, Kumer TL, et al. Fulminant hepatitis in a tropi- cal population : clinical course, cause, and early predictors of outcome. Hepatology, 1996,23 : 1448 - 1455.
1Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease. Hepatology, 2001, 33: 473-475.
2Everson GT. MELD: the answer or just more questions?Gastroenterology, 2003, 124: 251-254.
3Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology, 2000, 31: 864-871.
4Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology, 2001,33: 464-470.
5Robert A, Chazouilleres O. Prothrombin time in liver failure: time,ratio, activity percentage, or international normalized ratio?Hepatology, 1996, 24: 1392-1394.
6Freeman RB Jr, Wiesner RH, Harper A, et al. The new liver allocation system: moving toward evidence-based transplantation policy.Liver Transpl, 2002, 8: 851-858.
7Schaffer RL 3rd, Kulkarni S, Harper A, et al. The sickest first?Disparities with model for end-stage liver disease-based organ allocation: one region's experience. Liver Transpl, 2003, 9: 1211-1215.
8Brown RS Jr, Kumar KS, Russo MW, et al. Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome,and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl, 2002, 8: 278-284.
9Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology,2003, 124: 91-96.
10Wiesner RH, McDiarmid SV, Kamath PS, et al. MELD and PELD:application of survival models to liver allocation. Liver Transpl,2001, 7: 567-580.
